Regulatory Landscape of Regenerative Medicine in Japan


Last year, Japan exercised two new acts, the Act on the Safety of Regenerative Medicine (RM Act) and Pharmaceuticals and Medical Devices Act (PMD Act). These acts have significantly changed the conditions for clinical application of regenerative medicine. The RM Act covers clinical research and medical practice using processed cells. It specifies the… (More)
DOI: 10.1007/s40778-015-0012-6

4 Figures and Tables


  • Presentations referencing similar topics